Sjogren's Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment

Jennifer Behbodikhah1, Billy Ding1, Belin Jacob1

  • 1Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA.

Insights

Sjogren's Disease (SjD) may accelerate cardiovascular disease (CVD) risk, despite often being underrecognized. This review explores SjD's impact on heart health, potential mechanisms, and monitoring tools.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Autoimmune disorders accelerate atherosclerosis and cardiovascular disease (CVD).
  • Systemic lupus erythematosus and rheumatoid arthritis are linked to increased CVD.
  • Sjogren's Disease (SjD) has an indolent course, with its chronic inflammatory burden and CVD risk often underrecognized.

Purpose of the Study:

  • To review the association between Sjogren's Disease and cardiovascular disease.
  • To explore potential risk factors and mechanisms linking SjD to accelerated CVD.
  • To discuss the impact of CVD and SjD treatments on heart health and monitoring subclinical atherosclerosis in SjD patients.

Main Methods:

  • Literature review of studies investigating cardiovascular disease in Sjogren's Disease.
  • Analysis of potential mechanisms contributing to CVD in SjD.
  • Evaluation of current treatment impacts and monitoring tools for subclinical atherosclerosis.

Main Results:

  • Conflicting results exist regarding the direct link between SjD and CVD.
  • SjD's chronic inflammation may contribute to accelerated atherosclerosis.
  • Standard treatments for both CVD and SjD may influence cardiovascular outcomes.

Conclusions:

  • The relationship between Sjogren's Disease and cardiovascular disease requires further elucidation.
  • Identifying and managing CVD risk factors in SjD patients is crucial.
  • Clinically relevant tools for monitoring subclinical atherosclerosis are important for SjD patient care.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
492
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
402
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
447